These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27426453)

  • 1. Study of the structures of photodegradation impurities and pathways of photodegradation of cilnidipine by liquid chromatography/Q-Orbitrap mass spectrometry.
    Zeng H; Wang F; Zhu B; Zhong W; Shan W; Wang J
    Rapid Commun Mass Spectrom; 2016 Aug; 30(15):1771-8. PubMed ID: 27426453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation and characterization of unknown impurities and isomers in flomoxef sodium by LC-IT-TOF MS and study of their negative-ion fragmentation regularities.
    Yu X; Wang F; Li J; Shan W; Zhu B; Wang J
    J Pharm Biomed Anal; 2017 Jun; 140():81-90. PubMed ID: 28343077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and characterization of two series of unknown degradation impurities caused by light irradiation and autoclaving in xinfujunsu injection using liquid chromatography tandem mass spectrometry.
    Huang Q; Tang K; Ren X; Wang J
    Rapid Commun Mass Spectrom; 2022 Feb; 36(3):e9223. PubMed ID: 34773922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a trap-free two-dimensional liquid chromatography combined with ion trap/time-of-flight mass spectrometry for separation and characterization of impurities and isomers in cefpiramide.
    Wang J; Xu Y; Wen C; Wang Z
    Anal Chim Acta; 2017 Nov; 992():42-54. PubMed ID: 29054149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of eight unknown impurities and analysis of their source in xinfujunsu and injection by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry.
    Wang J; Tang K; Zhu B; Zheng S; Zheng J; Hong L
    J Pharm Biomed Anal; 2021 Sep; 204():114279. PubMed ID: 34340019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of teicoplanin impurities by two-dimensional ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry].
    Shao W; Chen Y; Yuan H; Jin M; Zhou X; Qin Y; Yang H; He Y
    Se Pu; 2023 Feb; 41(2):195-204. PubMed ID: 36725716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new component and impurities in josamycin by trap-free two-dimensional liquid chromatography coupled to ion trap time-of-flight mass spectrometry.
    Liu G; Xu Y; Sang J; Zhu B; Wang J
    Rapid Commun Mass Spectrom; 2019 Jun; 33(12):1058-1066. PubMed ID: 30907019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impurity profile of photodegradation in lomefloxacin hydrochloride ear drops using liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Zeng H; Yang Y; Gao J; Zhou Y; Zheng J
    Rapid Commun Mass Spectrom; 2024 May; 38(10):e9732. PubMed ID: 38525499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of impurities in the repurposed COVID-19 drug hydroxychloroquine sulfate using ultra-high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry and liquid chromatography-solid-phase extraction-nuclear magnetic resonance.
    Xu D; Pan F; Ruan H; Sun N
    Rapid Commun Mass Spectrom; 2022 Oct; 36(20):e9358. PubMed ID: 35880971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impurity profile and spectrum characteristics of the isomers in cefamandole nafate using high- performance liquid chromatography/high-performance size exclusion chromatography tandem ion trap/time-of-flight mass spectrometry.
    Wang F; Gao J; Chen H; Zhu B; Li P; Wang J; Hong L
    Rapid Commun Mass Spectrom; 2022 Dec; 36(23):e9399. PubMed ID: 36114650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impurity profile analysis of amphotericin B using on-line two-dimensional high performance liquid chromatography-quadrupole time-of-flight mass spectrometry].
    Weng RW; Wang XT; Wen HL; Liu H
    Se Pu; 2024 Apr; 42(5):432-444. PubMed ID: 38736386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation and characterization of unknown impurities in rutin tablets using trap-free two-dimensional liquid chromatography coupled with ion trap/time-of-flight mass spectrometry.
    Wang J; Ren X; Wen C; Xu Y; Chen Y
    Rapid Commun Mass Spectrom; 2020 May; 34(10):e8739. PubMed ID: 31986235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the impurity profile and influencing factors of photodegradation in non-aqueous ofloxacin ear drops using liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Xu B; Gao J; Zhu B; Li P; Su W; Wang J
    J Pharm Biomed Anal; 2023 Sep; 233():115476. PubMed ID: 37245330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and Characterization of Unknown Impurities and Isomers in Cefminox Sodium and Study of the Forming Mechanisms of Impurities by Liquid Chromatography Coupled with Ion Trap/Time-Of-Flight Mass Spectrometry.
    Xu Y; Wang D; Tang L; Wang J
    J Chromatogr Sci; 2019 Mar; 57(3):204-212. PubMed ID: 30395207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of four unknown impurities in azithromycin and erythromycin imino ether using two-dimensional liquid chromatography coupled to high-resolution quadrupole time-of-flight mass spectrometry and nuclear magnetic resonance.
    Jin Y; Xu Y; Zhou J; Zhou Z; Wang J
    Rapid Commun Mass Spectrom; 2020 Jun; 34(11):e8772. PubMed ID: 32112476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation and characterization of unknown impurities in latamoxef sodium by LC-Q-TOF MS and a summary of their positive-ion fragmentation regularities.
    He L; Qian J; Zhu P; Yang W; She Y
    J Pharm Biomed Anal; 2019 Oct; 175():112793. PubMed ID: 31377652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of impurities in an insecticide, commercial chlorantraniliprole using liquid chromatography-tandem mass spectrometry.
    Kannoujia J; Chirra N; Rodda R; Shaikh A; Maddala N; Kantevari S; Sripadi P
    Rapid Commun Mass Spectrom; 2024 May; 38(9):e9729. PubMed ID: 38456250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Separation and identification of impurities from intermediates of istradefylline].
    Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M
    Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel HPLC method for the determination of the impurities in desonide cream and characterization of its impurities by 2D LC-IT-TOF MS.
    Wang J; Zheng S; Xu Y; Hu H; Shen M; Tang L
    J Pharm Biomed Anal; 2018 Nov; 161():399-406. PubMed ID: 30205304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two unknown impurities in roxithromycin by 2D LC-QTOF/MS/MS and NMR.
    Wang J; Zhou J; Xu Y; Zhu B; Jin Y
    J Pharm Biomed Anal; 2020 May; 184():113196. PubMed ID: 32113121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.